A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2007

Study Completion Date

August 31, 2007

Conditions
HIV Infections
Interventions
DRUG

dapivirine reservoir intravaginal ring

a silicone elastomer reservoir ring containing 25mg of dapivirine

DRUG

dapivirine matrix intravaginal ring

a silicone elastomer matrix intravaginal ring containing 25mg of dapivirine

OTHER

placebo intravaginal ring

a silicone elastomer intravaginal ring containing no dapivirine

Trial Locations (1)

9000

Drug Research Unit Ghent (D.R.U.G.), Ghent

All Listed Sponsors
lead

International Partnership for Microbicides, Inc.

INDUSTRY

NCT00469768 - A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium | Biotech Hunter | Biotech Hunter